Market Access: Pharma

Real-World Evidence Strategy and Plan

Leveraging in-depth data solutions and expertise

Alira Health offers a range of real-world evidence strategy and planning, aimed at delivering commercial success. Our teams work closely with you to:
  • Define internal and external dissemination strategies
  • Advise on data extraction, data analysis, and data specification documents (e.g., protocols and study reports)
  • Develop protocols, manuscripts, and study reports
  • Conduct systematic literature reviews
  • Manage external database owners and programmers

Why choose Alira Health?

As your partner, we’ll work closely with you to uncover opportunities across the pharma industry, accelerate innovation, and deliver tomorrow’s standard of care. You’ll benefit from our:

  • Access to a diverse

    integrated team with deep industry expertise

  • Close collaboration

    with our regulatory and clinical

  • Specific, local insights

    as part of your larger, global strategy—a benefit of having market access teams in both the EU and U.S.

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Jean-François Ricci
Jean-François Ricci
Executive Vice President, Global Market Access
Our strong client partnerships allow us to deliver in-depth, customized strategies and access solutions—all designed to maximize product value across its full lifecycle.

Related News

Pharma
Events October 13, 2021
Event: World Drug Safety Congress
Join our team of experts at World Drug Safety Congress in Boston, MA.
Pharma
Events October 1, 2021
Event: Meeting on the Mesa
Join us at Meeting on the Mesa in Carlsbad, CA on October 11-14, 2021.
Market Access
Publications September 28, 2021
Alira Health Published in Business Development & Licensing Journal
Experts from the Alira Health team recently shared their thoughts regarding the importance of market access insights for the success of licensing operations with professionals from(...)
Pharma Research & Development
Publications August 2, 2021
Infographic: Prioritization Strategy of R&D Targets for Biotech Company
Download our infographic on Prioritization Strategy of R&D Targets for Biotech Company
Due Diligence Pharma
News July 21, 2021
Alira Health Announces its Role as Strategic Advisor to Naxicap
Alira Health is proud to announce its role as strategic advisor to Naxicap in the equity investment in Ceres Pharma Bv.
Digital Health Market Access
Publications April 20, 2021
Health Economics Evaluation and Value Proposition for an Antimicrobial Medical Device in the U.S. Market
A health economics evaluation assists companies during product development to better understand the product's impact across the ecosystem and position it appropriately.
Due Diligence MedTech Patient Engagement Pharma
Multimedia April 12, 2021
Evolution of the Drug Delivery Systems Industry and its Increasing Role in Driving Patient Outcomes
In the third episode, Amira Ghozali, Aptar Pharma, Kenny Carberry, and Aude Ouensanga, discuss the evolution of the DDS industry, its relationship with Pharma, and its increasing role(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.